Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination
Abstract Background Vaccine‐induced immune thrombotic thrombocytopenia (VITT) is a rare distinctive syndrome characterized by unusual site thrombosis accompanied by thrombocytopenia after ChAdOx1 nCoV‐19 vaccination. Platelet‐activating anti–platelet factor 4–dependent antibodies (anti‐PF4 Abs) were...
Main Authors: | Noppacharn Uaprasert, Phandee Watanaboonyongcharoen, Rattaporn Vichitratchaneekorn, Sasinipa Trithiphen, Benjaporn Akkawat, Autcharaporn Sukperm, Thanisa Tongbai, Watsamon Jantarabenjakul, Leilani Paitoonpong, Ponlapat Rojnuckarin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12580 |
Similar Items
-
Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies
by: Noppacharn Uaprasert, et al.
Published: (2021-12-01) -
Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
by: Thiti Asawapanumas, et al.
Published: (2022-01-01) -
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
by: Noppacharn Uaprasert, et al.
Published: (2022-12-01) -
Comprehensive Hematological and molecular Characterization of hemoglobin Hekinan [α27(B8)Glu→Asp(α1), HBA1:c.84G > T] in a Large Thai cohort
by: Amornchai Suksusut, et al.
Published: (2025-12-01) -
Antiplatelet activity of deferiprone through cyclooxygenase-1 inhibition
by: Ngan Thi Tran, et al.
Published: (2020-05-01)